Amarin Corp Plcuk (AMRN) Other Working Capital Changes (2010 - 2026)
Amarin Corp Plcuk (AMRN) posted quarterly Other Working Capital Changes of $2.0 million for Q1 2026, down 84.34% YoY from $12.6 million in Q1 2025, and down 84.35% sequentially from $12.6 million in Q4 2025.
Amarin Corp Plcuk (AMRN) Other Working Capital Changes (2010 - 2026) Analysis & Trends
Amarin Corp Plcuk has disclosed Other Working Capital Changes across 17 years of filings, most recently posting $2.0 million for Q1 2026.
- In Q1 2026, Other Working Capital Changes fell 84.34% year-over-year to $2.0 million; the TTM figure through Mar 2026 stood at $1.8 million (down 77.25% YoY), while the FY2025 annual figure was $5.2 million, up 1234.96% from the prior year.
- Other Working Capital Changes slipped to $2.0 million in Q1 2026, from $12.6 million in the prior quarter.
- Over the last five years, Other Working Capital Changes for AMRN reached as high as $24.3 million in Q2 2023 and fell as low as -$34.2 million in Q3 2023.
- The 5-year median for Other Working Capital Changes is $260000.0 (2022), against an average of -$72375.0.
- The widest YoY moves for Other Working Capital Changes: up 5338.42% in 2022, down 905.78% in 2022.
- A 5-year view of Other Working Capital Changes shows it stood at -$5.5 million in 2022, then surged by 145.79% to $2.5 million in 2023, then plunged by 1092.15% to -$24.8 million in 2024, then jumped by 150.79% to $12.6 million in 2025, then sank by 84.35% to $2.0 million in 2026.
- According to Business Quant data, Other Working Capital Changes over the past three periods registered $2.0 million, $12.6 million, and -$115000.0 for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Eli Lilly | 1,066.16 Bn | 1,060.88 Bn | 16.22 Bn |
| 2 | Johnson & Johnson | 611.69 Bn | 589.64 Bn | 15.96 Bn |
| 3 | AbbVie | 444.34 Bn | 434.99 Bn | 10.78 Bn |
| 4 | Astrazeneca | 284.94 Bn | 277.05 Bn | 12.61 Bn |
| 5 | Merck | 224.23 Bn | 218.58 Bn | 12.09 Bn |
| 6 | Amgen | 195.12 Bn | 183.08 Bn | 5.87 Bn |
| 7 | Gilead Sciences | 156.45 Bn | 148.73 Bn | 5.52 Bn |
| 8 | Pfizer | 136.01 Bn | 123.24 Bn | -1.21 Bn |
| 9 | Novartis Ag | 113.45 Bn | 113.67 Bn | - |
| 10 | Amarin Corp Plcuk | 5.17 Bn | 5.00 Bn | 17.77 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 1.97 Mn |
| Mar 31, 2026 | 1.97 Mn |
| Mar 31, 2026 | 1.97 Mn |
| Dec 31, 2025 | 12.59 Mn |
| Dec 31, 2025 | 12.59 Mn |
| Dec 31, 2025 | 12.59 Mn |
| Sep 30, 2025 | -115,000.00 |
| Sep 30, 2025 | -115,000.00 |
| Sep 30, 2025 | -115,000.00 |
| Jun 30, 2025 | -12.59 Mn |
| Jun 30, 2025 | -12.59 Mn |
| Jun 30, 2025 | -12.59 Mn |
| Mar 31, 2025 | 12.58 Mn |
| Mar 31, 2025 | 12.58 Mn |
| Mar 31, 2025 | 12.58 Mn |
| Sep 30, 2024 | -24.78 Mn |
| Sep 30, 2024 | -24.78 Mn |
| Sep 30, 2024 | -24.78 Mn |
| Jun 30, 2024 | 20.34 Mn |
| Jun 30, 2024 | 20.34 Mn |